Top pharma firms in new batch of strategic businesses
The director-general of the Office for Attracting Strategic Enterprises (Oases) on Sunday said the next batch of strategic enterprises would include top pharmaceutical companies, which would conduct clinical trials as well as medicinal research and development in Hong Kong. In total, Peter Yan said there would be around 10 to 20 firms in this intake, split evenly between mainland and overseas…
Read original article on rthk.hk - Express News: Local →Related news
-
More drug, semiconductor firms eyeing Hong Kong for expansion, OASES head says
-
Hong Kong ‘optimistic’ on economic growth despite global slowdown, Paul Chan says
-
Cherish peace and stability, John Lee urges Hongkongers during Chung Yeung Festival
-
Banking on bricks: entrepreneur builds a business case for recycling plastic waste
-
Harvard and Cambridge to attend Hong Kong forum on role of humanities in AI age
-
CE calls for cherishing peace as HK honours heroes
-
Spirit of Hong Kong Awards finalist bridges the gap in accessible dental care
-
Why is Hong Kong hosting the Apec Finance Ministers’ Meeting? There is another agenda